Cytokinetics, Inc. (CYTK)
60.70
-1.49
(-2.40%)
USD |
NASDAQ |
Mar 06, 15:54
Cytokinetics Cash from Investing (Quarterly) : -71.19M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | -1.458B |
| Molina Healthcare, Inc. | 230.00M |
| Lifecore Biomedical, Inc. | -1.737M |
| Corcept Therapeutics, Inc. | -11.84M |
| Ionis Pharmaceuticals, Inc. | -419.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -142.65M |
| Cash from Financing (Quarterly) | 110.70M |
| Free Cash Flow | -534.82M |
| Free Cash Flow Per Share (Quarterly) | -1.211 |
| Free Cash Flow to Equity (Quarterly) | -235.68M |
| Free Cash Flow to Firm (Quarterly) | -117.96M |
| Free Cash Flow Yield | -7.34% |